IGF-IRα (1H7) Antibody sc-461 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemIGF-IRα (1H7) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-461
NCBI Gene AliasesIGFR, D930020L01, IGFIR, A330103N21Rik, CD221, IGF-1R, JTK13, hyft
Antibody TypePrimary Antibodies
Quantity200 µg/ml
Clone1H7
ApplicationsIP, IF, IHC(P), FCM
Reactivitymouse, rat, human
ClonalityMonoclonal
FormatPurified
Hostmouse
Conjugate/TagUnconjugated
NCBI Full Gene Nameinsulin like growth factor 1 receptor, insulin-like growth factor I receptor
TargetIGF-IRalpha
IsotypeIgG1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasisCommunications biologyJuly 20, 2023Chakraborty S, Bhat AM, Mushtaq I, Luan H, Kalluchi A, Mirza S, Storck MD, Chaturvedi N, Lopez-Guerrero JA, Llombart-Bosch A, et al.

(2) Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patientsOncotargetJanuary 1, 2022Molina ER, Chim LK, Lamhamedi-Cherradi SE, Mohiuddin S, McCall D, Cuglievan B, Krishnan S, Porter RW, Ingram DR, Wang WL, et al.antibodies used were targeted to YAP (Santa Cruz, sc-271134), TAZ (Abcam, ab-84927), IGF-1R (Santa Cruz, sc-461), and pIGF-1R (Santa Cruz, sc-101703). Samples were then washed three times with 1 × PBS before incubating

(3) Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expressionEye (London, England)September 1, 2021Ugradar S, Shi L, Wang Y, Mester T, Yang H, Douglas RS.

(4) Insulin-like Growth Factor 1 Supports a Pulmonary Niche that Promotes Type 3 Innate Lymphoid Cell Development in Newborn LungsImmunityFebruary 18, 2020Oherle K, Acker E, Bonfield M, Wang T, Gray J, Lang I, Bridges J, Lewkowich I, Xu Y, Ahlfeld S, et al.antibodies, alveolar aggregates were incubated with either anti-IGF1 antibody (0.5 micro g ml−1) (Santa Cruz, SC 461) or anti-IL33R antibody (1 micro g ml−1) (R&D Biosystems, AF 1004) or anti-IgG antibody (0.5 micro g

(5) Search of reference biomarkers reflecting orbital tissue remodeling in the course of Graves' orbitopathyFolia histochemica et cytobiologicaJanuary 1, 2020Pawlowski P, Poplawska I, Mysliwiec J, Dik WA, Eckstein A, Berchner-Pfannschmidt U, Milewski R, Lawicki S, Dzieciol-Anikiej Z, Rejdak R, et al.

(6) Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcomaActa biomaterialiaDecember 1, 2019Molina ER, Chim LK, Salazar MC, Mehta SM, Menegaz BA, Lamhamedi-Cherradi SE, Satish T, Mohiuddin S, McCall D, Zaske AM, et al.immunocytochemistry were targeted to YAP (Santa Cruz, sc-271134), TAZ (abcam, ab-84927), IGF-1R (Santa Cruz, sc-461) and pIGF-1R (Santa Cruz, sc-101703). Samples were then washed 3 times with 1× PBS before incubating

(7) MiR-615-5p depresses natural killer cells cytotoxicity through repressing IGF-1R in hepatocellular carcinoma patientsGrowth factors (Chur, Switzerland)June 1, 2017Rahmoon MA, Youness RA, Gomaa AI, Hamza MT, Waked I, El Tayebi HM, Abdelaziz AI.

(8) Low Oxygen Tension Modulates the Insulin-Like Growth Factor-1 or -2 Signaling via Both Insulin-Like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem CellsEndocrinologyMarch 1, 2016Youssef A, Han VK.

(9) Abrogating the interplay between IGF2BP1, 2 and 3 and IGF1R by let-7i arrests hepatocellular carcinoma growthGrowth factors (Chur, Switzerland)February 1, 2016Fawzy IO, Hamza MT, Hosny KA, Esmat G, Abdelaziz AI.

(10) Crucial role of TRPC6 in maintaining the stability of HIF-1α in glioma cells under hypoxiaJournal of cell scienceSeptember 1, 2015Li S, Wang J, Wei Y, Liu Y, Ding X, Dong B, Xu Y, Wang Y.

(11) miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinomaFEBS lettersAugust 4, 2015Fawzy IO, Hamza MT, Hosny KA, Esmat G, El Tayebi HM, Abdelaziz AI.

(12) Targeted killing of cancer cells in vivo and in vitro with IGF-IR antibody-directed carbon nanohorns based drug deliveryInternational journal of pharmaceuticsJanuary 30, 2015Li N, Zhao Q, Shu C, Ma X, Li R, Shen H, Zhong W.

(13) Resistin decreases insulin-like growth factor I-induced steroid production and insulin-like growth factor I receptor signaling in human granulosa cellsFertility and sterilityJuly 1, 2013Reverchon M, Cornuau M, Ramé C, Guerif F, Royère D, Dupont J.

(14) Epitope-specific mechanisms of IGF1R inhibition by ganitumabPloS oneJanuary 1, 2013Calzone FJ, Cajulis E, Chung YA, Tsai MM, Mitchell P, Lu J, Chen C, Sun J, Radinsky R, Kendall R, et al.

(15) Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literatureSarcomaJanuary 1, 2013O'Neill A, Shah N, Zitomersky N, Ladanyi M, Shukla N, Uren A, Loeb D, Toretsky J.lysate. 2.4. Flow Cytometric Analysis. ES cells were stained with Alde�uor and/or IGF-1R𝛼𝛼 (1H7): sc-461 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) according to the manufacturer’s instructions. e

(16) Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell linesPloS oneJanuary 1, 2012Chang CH, Wang Y, Trisal P, Li R, Rossi DL, Nair A, Gupta P, Losman M, Cardillo TM, Rossi EA, et al.

(17) Characterization of proliferative effects of insulin, insulin analogues and insulin-like growth factor-1 (IGF-1) in human lung fibroblastsNaunyn-Schmiedeberg's archives of pharmacologyDecember 1, 2010Warnken M, Reitzenstein U, Sommer A, Fuhrmann M, Mayer P, Enzmann H, Juergens UR, Racké K.

(18) beta-Arrestin 2-mediated heterologous desensitization of IGF-IR by prolonged exposure of SH-SY5Y neuroblastoma cells to a mu opioid agonistFEBS lettersAugust 20, 2010Spartà A, Baiula M, Campbell G, Spampinato S.

(19) Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent mannerClinical cancer research : an official journal of the American Association for Cancer ResearchMarch 1, 2009Schayek H, Haugk K, Sun S, True LD, Plymate SR, Werner H.(Cat. number sc-7867, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and IGF-IR α-subunit (Cat. number sc-461, Santa Cruz Biotechnology) were used to stain the TMAs. BRCA1 blocking peptide Cat. number #ab40076

(20) Insulin receptor substrate-2 mediated insulin-like growth factor-I receptor overexpression in pancreatic adenocarcinoma through protein kinase CdeltaCancer researchFebruary 15, 2009Kwon J, Stephan S, Mukhopadhyay A, Muders MH, Dutta SK, Lau JS, Mukhopadhyay D.

Be the First to Write a Review!

IGF-IRα (1H7) Antibody

IGF-IRα (1H7) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (52)

Reviews

IGF-IRα (1H7) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map